“…In addition, the T3SS has been exploited for delivery of heterologous antigens by live attenuated Yersinia carrier vaccines (3,32,55,62,65,67,70). Evidence was obtained that YopP inhibited CD8 T-cell priming to a heterologous antigen in mice infected with a Y. enterocolitica carrier vaccine strain (32,65,67).…”